AS601245
Cat. No.:YN350066
CAS No. :345987-15-7
产品名称: | AS601245 |
CAS No.: | 345987-15-7 |
Chemical Name: | a-[2-[[2-(3-pyridinyl)ethyl]amino]-4-pyrimidinyl]-2-benzothiazoleacetonitrile |
Synonyms: | AS-601245 |
分子量: | 372.45 |
分子式: | C₂₀H₁₆N₆S |
SMILES: | N#CC(C1=CC=NC(NCCC2=CC=CN=C2)=N1)C3=NC4=CC=CC=C4S3 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | AS601245 是一种细胞可渗透性的JNK抑制剂,抑制hJNK1,hJNK2和hJNK3,IC50分别为 150, 220 和 70 nM。 |
IC50和靶点: | [{name:"hJNK1:150 nM (IC50)"},{name: "hJNK2:220 nM (IC50)"},{name: "hJNK3:70 nM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Johnson, G.L., and Lapadat, R.Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinasesScience298(5600),1911-1912(2002)
Gaillard, P., Jeanclaude-Etter, I., Ardissone, V., et al.Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinaseJ. Med. Chem.48(14),4596-4607(2005)
Carboni, S., Hiver, A., Szyndralewiez, C., et al.AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective propertiesJ. Pharmacol. Exp. Ther.310(1),25-32(2004)
Fedorov, O., Marsden, B., Pogacic, V., et al.A systematic interaction map of validated kinase inhibitors with Ser/Thr kinasesProc. Natl. Acad. Sci. USA104(51),20523-20528(2007)
Ferrandi, C., Ballerio, R., Gaillard, P., et al.Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized ratsBr. J. Pharmacol.142(6),953-960(2004)
Oktem, O., Buyuk, E., and Oktay, K.Preantral follicle growth is regulated by c-Jun-N-terminal kinase (JNK) pathwayReprod.Sci.18(3),269-276(2011)
Tu, Y.F., Tsai, Y.S., Wang, L.W., et al.Overweight worsens apoptosis, neuroinflammation and blood-brain barrier damage after hypoxic ischemia in neonatal brain through JNK hyperactivationJ. Neuroinflammation8:40,(2011)